5 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Famotidine Suspension in dosage form, from India
Issued November 5, 2021 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN3 N322136 (November 5, 2021)
Tariff classification
HTS codes: 3004.90.9260
Headings: 3004
Product description
Famotidine Suspension, imported in 40 mg/5 ml, is a histamine-2 blocker that works by decreasing the amount of acid the stomach produces. It is used to treat duodenal ulcers, benign gastric ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.
CBP rationale
The applicable subheading for the Famotidine Suspension in dosage form will be 3004.90.9260, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Medicaments primarily affecting the digestive system: Other.
Full text
N322136 November 5, 2021 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9260 Mrs. Rhona M. Keeler NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road, Cork T12 XN72 Ireland RE: The tariff classification of Famotidine Suspension in dosage form, from India Dear Mrs. Keeler: In your letter dated October 11, 2021, you requested a tariff classification ruling. Famotidine Suspension, imported in 40 mg/5 ml, is a histamine-2 blocker that works by decreasing the amount of acid the stomach produces. It is used to treat duodenal ulcers, benign gastric ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. The applicable subheading for the Famotidine Suspension in dosage form will be 3004.90.9260, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Medicaments primarily affecting the digestive system: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Balsalazide Disodium Capsules USP and Carbidopa Tablets in dosage form, from Taiwan and India, respectively
The tariff classification of Loperamide Hydrochloride Capsules, USP and Methylene Blue Injection, USP in dosage form, from India and Italy, respectively
The tariff classification of Pantoprazole Sodium for Injection in dosage form, from India
The tariff classification of Fesoterodine Fumarate Extended-Release Tablets, Famotidine Tablets and Lenalidomide Capsules, in dosage form, from India
The tariff classification of Lansoprazole Delayed-Release Orally Disintegrating Tablets in dosage form, from India
The tariff classification of Mesalamine Suppositories in dosage form, from Italy
The tariff classification and country of origin of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, 5 mg/2.5 mg
The tariff classification of Ondansetron Tablets in dosage form, from India
The tariff classification of Desvenlafaxine Extended Release Tablets and Mesalamine Extended Release Capsules from India
The tariff classification of Lansoprazole DR Tablets in dosage form, from India
Follow N322136
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.